Maynard Um
-
-
-
-
-
-
-
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
-
-
-
-
-
-
-
Therma Bright Announces Share Consolidation
-
-
-
-
-
-
-
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
-
-
-
-
-
-
-
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
-
-
-
-
-
-
-
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
-
-
-
-
-
-
-
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
-
-
-
-
-
-
-
Therma Bright Q2, 2024 Market Update On Business
-
426,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

